Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions - Top-Institutions - MDSpire

Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions

  • By

  • Jiasheng Zhou

  • Bo Liu

  • Qiao Yang

  • Jingxuan Zhou

  • Jiahao Zheng

  • Yujin Chen

  • Lie Fu

  • Jianhui Du

  • Zhegang Zhang

  • Jiayou Zhang

  • Changgui Li

  • July 16, 2026

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Access to Advanced Health Institute
    Access to Advanced Health Institute

    Seattle, Washington

    Key Differentiators

    • Immunology
    • Infectious Disease

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, Washington

    Key Differentiators

    • Immunology
    • Cancer Research

Original Source(s)

Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions

  • by Jiasheng Zhou, Bo Liu, Qiao Yang, Jingxuan Zhou, Jiahao Zheng, Yujin Chen, Lie Fu, Jianhui Du, Zhegang Zhang, Jiayou Zhang, Changgui Li

  • July 16, 2026

Related Content

Association between early postnatal antibiotic exposure and bronchopulmonary dysplasia in very preterm infants: a meta-analysis

Associations between multidimensional fatigue and wearable-derived cardio-respiratory variables in post-COVID-19 patients: an observational study

Case Report: Persistent indirect hyperbilirubinemia caused by Gilbert syndrome misdiagnosed as drug-induced liver injury during tuberculosis treatment